Mirae Asset Global Investments Co., Ltd. Sutro Biopharma, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,676 shares of STRO stock, worth $2,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,676
Previous 2,748
2.62%
Holding current value
$2,408
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding STRO
# of Institutions
131Shares Held
60.1MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.72 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$6.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$3.79 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$3.28 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$2.31 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $46.9M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...